换一批Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone.
第一作者：
G,Derosa
第一单位：
Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. giuseppe.derosa@unipv.it
作者：
医学主题词
脂联素(Adiponectin);投药, 口服(Administration, Oral);成年人(Adult);血管紧张素Ⅱ1型受体拮抗剂(Angiotensin II Type 1 Receptor Blockers);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);苯咪唑类(Benzimidazoles);苯甲酸盐类(Benzoates);联苯化合物(Biphenyl Compounds);血糖(Blood Glucose);血压(Blood Pressure);人体质量指数(Body Mass Index);糖尿病, 2型(Diabetes Mellitus, Type 2);剂量效应关系, 药物(Dose-Response Relationship, Drug);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);降血糖药(Hypoglycemic Agents);脂类(Lipids);男(雄)性(Male);抵抗素(Resistin);四唑类(Tetrazoles);噻唑烷二酮类(Thiazolidinediones);治疗结果(Treatment Outcome)
DOI
10.1111/j.1365-2710.2007.00820.x
PMID
17489878
发布时间
2022-12-07
- 浏览30
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
